{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:13:09Z","timestamp":1793333589005,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor outcomes and high recurrence. Disulfidptosis, a novel form of programmed cell death driven by aberrant disulfide bonds and F-actin collapse, provides insights into cancer progression and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated the correlation network and prognostic values of disulfidptosis-related genes (DRGs) in AML. Unsupervised clustering was performed to reveal distinct disulfidptosis-related AML subtypes. We implemented the differential analysis and enrichment analysis to explore the difference of the distinct subtypes in biological processes. Least absolute shrinkage and selection operator (LASSO) Cox model was used to generate a disulfidptosis-related signature. We employed the ESTIMATE, CIBERSORT, and scRNA analyses to assess the tumor microenvironment of AML. Moreover, experiments validated the functions of PTPN6 and CSK in OCI-AML2 cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 10 prognostic DRGs and revealed two disulfidptosis subtypes. DRGs significantly affected immune processes like interferon-gamma response and MHC class II antigen presentation. LASSO algorithm was implemented to established a 6-gene signature (HLA-DRB5, CCDC124, PTPN6, HLA-DMA, CSK, ISG15) that predicted prognosis in two validation cohorts more robustly than other signatures. Disulfidptosis was correlated with tumor microenvironment immune cells, especially monocytes. The two risk subgroups differed significantly in susceptibilities of multiple chemotherapy drugs, indicating disulfidptosis as a potential therapeutic target. Knockdown of PTPN6 and CSK inhibited the proliferation of AML cells and increased apoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study provides insights into DRG prognoses and immunomodulation, establishing a robust 6-gene risk model for predicting AML outcomes that may enhance precision medicine and treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1513040","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:31:22Z","timestamp":1743791482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Han","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.349368.122","article-title":"Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic","volume":"36","author":"Bewersdorf","year":"2022","journal-title":"Genes Dev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in Acute Myeloid Leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02417-1","article-title":"Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia","volume":"38","author":"Patel","year":"2024","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.v4.4","article-title":"Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions","volume":"4","author":"Patel","year":"2023","journal-title":"EJHaem"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1957869","article-title":"Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia","volume":"62","author":"Patel","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.695865","article-title":"Prognosis and characterization of immune microenvironment in acute myeloid leukemia through identification of an autophagy-related signature","volume":"12","author":"Fu","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discovery"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12935-021-01821-2","article-title":"Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.178442","article-title":"A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia","volume":"103","author":"Herold","year":"2018","journal-title":"Haematologica"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3184","article-title":"Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study","volume":"31","author":"Li","year":"2013","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148483","article-title":"Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac033","article-title":"Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Neuro Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"120142","DOI":"10.1016\/j.biomaterials.2020.120142","article-title":"Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy","volume":"254","author":"Zhao","year":"2020","journal-title":"Biomaterials"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/leu.2017.30","article-title":"Biological and clinical consequences of NPM1 mutations in AML","volume":"31","author":"Heath","year":"2017","journal-title":"Leukemia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013156","article-title":"Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2","volume":"139","author":"Mill","year":"2022","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","article-title":"Disulfidptosis: a new target for metabolic cancer therapy","volume":"42","author":"Zheng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu Rev Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1040661","article-title":"A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia","volume":"13","author":"Hua","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.006","article-title":"Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential","volume":"30","author":"Chen","year":"2016","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"152049","DOI":"10.1016\/j.imbio.2020.152049","article-title":"The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression","volume":"226","author":"Antohe","year":"2021","journal-title":"Immunobiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S268986","article-title":"Correlation study on HLA-DR and CD117 (c-kit) expressions: its prognosis and treatment response in acute myeloid leukemia patients","volume":"14","author":"El-Meligui","year":"2021","journal-title":"Pharmgenomics Pers Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-200802","article-title":"Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers","volume":"31","author":"Arslan","year":"2021","journal-title":"Cancer biomark"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1478-811X-10-19","article-title":"Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression","volume":"10","author":"Arora","year":"2012","journal-title":"Cell Commun Signal"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1087938","article-title":"Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2022.2096230","article-title":"Identification of the integrated prognostic signature associated with immuno-relevant genes and long non-coding RNAs in acute myeloid leukemia","volume":"40","author":"Zhao","year":"2022","journal-title":"Cancer Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.10.082","article-title":"c-Src activation through a TrkA and c-Src interaction is essential for cell proliferation and hematological Malignancies","volume":"441","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1074\/mcp.RA120.002169","article-title":"A proteomic approach to understand the clinical significance of acute myeloid leukemia-derived extracellular vesicles reflecting essential characteristics of leukemia","volume":"20","author":"Kang","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/ijms23010514","article-title":"Acute myeloid leukemia-related proteins modified by ubiquitin and ubiquitin-like proteins","volume":"23","author":"Park","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12614","article-title":"Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells","volume":"14","author":"Orfali","year":"2020","journal-title":"Mol Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ccell.2021.06.003","article-title":"The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance","volume":"39","author":"Joshi","year":"2021","journal-title":"Cancer Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1966779","article-title":"Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy","volume":"63","author":"Patel","year":"2022","journal-title":"Leuk Lymphoma"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:31:23Z","timestamp":1743791483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1513040"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1513040","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1513040"}}